Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach

For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate outcome is poor. Recently, the programmed cell death protein-1 (PD-1) inhibitors have shown remarkable efficacy in patients with refractory/rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaloyannidis, Panayotis, Al Shaibani, Eshrak, Moinnudin, Asif, Al Anezi, Khalid, Al Hashmi, Hani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967268/
https://www.ncbi.nlm.nih.gov/pubmed/33747411
http://dx.doi.org/10.4081/hr.2021.8780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967268/
https://www.ncbi.nlm.nih.gov/pubmed/33747411
http://dx.doi.org/10.4081/hr.2021.8780

Ejemplares similares